Search Results 2131-2140 of 18819 for Relapse
... relapse, and subsequent therapy. A Study of Nab-Paclitaxel as Maintenance Treatment After Cisplatin-Based Chemotherapy and Surgery for Patients with High ...
Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND. Treatment ...
... relapsed NSCLC. MC230818 Understanding the mechanisms of clonal and non-clonal cytopenia following CAR-T therapy (MC230818). Mankato, Minn., Rochester, Minn ...
Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND. Rare ...
... relapse. Results of the international MRC UKALLXII/ECOG E2993 trial. Br J Haematol. 2020 Oct; 191 (1):37-43 Epub 2020 Mar 27. View PubMed; Pogosova-Agadjanyan ...
Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I ...
Patients with current local, loco-regional relapse and/or distant metastatic breast cancer. Patients with a history of prior (ipsi- and/or contralateral) ...
This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease. It should only be used ...
Central nervous system relapse in patients with untreated HER2-positive esophageal or gastroesophageal junction adenocarcinoma. Int J Cancer. 2016 Oct 1 ...
Rochester, Minn. This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.